A recent study suggests that people who come off popular GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds far faster than those who halt conventional lifestyle plans.
Findings released in a major health publication demonstrates that while overweight individuals often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Users buying such treatments should be aware of the potential of fast rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
Such speed of recovery implies a return to starting mass in about one and a half years.
Analyzing Approaches
The study, which reviewed dozens of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers emphasize that people who shed pounds through dieting generally experience a slower weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Nutrition scientists propose the way of the jabs accounts for the heightened regain.
The injections imitate a body's own chemical called GLP-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making excessive eating a significant risk."
A Lifelong Issue?
The NHS recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, given the significant potential of weight regain, the therapy should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," akin to managing conditions like hypertension.
User Testimonies
Individuals who have stopped the jabs report a sudden resurgence of hunger.
"It was like a switch that goes on and you become starving," described a patient.
This challenge is worsened if patients have not adopted lasting lifestyle or habit changes during treatment.
Significant Use
Survey data show that millions of people in the UK have used these injections in the past year, with interest being substantial.
- Use is greater among females than males.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle management.
